TY - JOUR
T1 - Regulation of cyclic amp level and synthesis of DNA, RNA and protein by quercetin in ehrlich ascites tumor cells
AU - Graziani, Y.
AU - Chayoth, R.
PY - 1979/1/1
Y1 - 1979/1/1
N2 - Quercetin (3.3, 4′, 5.7-pentahydroxy flavone) at the concentration of 10-4 M as well as 10-2 M theophylline and 10-3 M dibutyryl cyclic AMP caused at least 85 per cent inhibition of [3H]thymidine incorporation in Ehrlich ascites tumor cells. At the same concentrations, these drugs decreased [3H]uridine and [3H]-L-leucine incorporation by 50-60 per cent and 35-45 per cent respectively. Ouabain (10-3 M), the specific inhibitor of Na+-K+ pump system, did not alter the incorporation of [3H]thymidine and [3]uridine, but decreased the incorporation of [3H]-L-leucine in these cells. Treatment of Ehrlich ascites tumor cells with the polyanion dextran sulfate did not change the inhibitory effect of quercetin, theophylline and dibutyrlyl cyclic AMP on [3H]thymidine incorporation. On the other hand, this polyanion decreased the inhibitory effect of these drugs on incorporation of [3H]uridine and abolished completely their effect on incorporation of [3H]-L-leucine.
AB - Quercetin (3.3, 4′, 5.7-pentahydroxy flavone) at the concentration of 10-4 M as well as 10-2 M theophylline and 10-3 M dibutyryl cyclic AMP caused at least 85 per cent inhibition of [3H]thymidine incorporation in Ehrlich ascites tumor cells. At the same concentrations, these drugs decreased [3H]uridine and [3H]-L-leucine incorporation by 50-60 per cent and 35-45 per cent respectively. Ouabain (10-3 M), the specific inhibitor of Na+-K+ pump system, did not alter the incorporation of [3H]thymidine and [3]uridine, but decreased the incorporation of [3H]-L-leucine in these cells. Treatment of Ehrlich ascites tumor cells with the polyanion dextran sulfate did not change the inhibitory effect of quercetin, theophylline and dibutyrlyl cyclic AMP on [3H]thymidine incorporation. On the other hand, this polyanion decreased the inhibitory effect of these drugs on incorporation of [3H]uridine and abolished completely their effect on incorporation of [3H]-L-leucine.
UR - https://www.scopus.com/pages/publications/0018337025
U2 - 10.1016/0006-2952(79)90105-9
DO - 10.1016/0006-2952(79)90105-9
M3 - Article
AN - SCOPUS:0018337025
SN - 0006-2952
VL - 28
SP - 397
EP - 403
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 3
ER -